Journal article · 2021

Lurasidone in schizophrenia in adolescents: a profile of its use

Matt Shirley

Drugs & Therapy Perspectives, 37(8), 347–353 · Published 1 August 2021 · DOI 10.1007/s40267-021-00849-8

View at the publisherCite this paper

In brief

“Lurasidone in schizophrenia in adolescents: a profile of its use” is a 2021 journal article by Matt Shirley, published in Drugs & Therapy Perspectives. OpenAlex counts 3 citations as of 20 November 2026. The publisher's version is not open access, and OpenAlex records no free legal copy.

Citations
3
Most cited in
2022 (1)
Field-weighted impact
0.28
References
14
Authors
1

Cite this paper

Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.

APA 7

Shirley, M. (2021). Lurasidone in schizophrenia in adolescents: a profile of its use. Drugs & Therapy Perspectives, 37(8), 347–353. https://doi.org/10.1007/s40267-021-00849-8

MLA 9

Shirley, Matt. “Lurasidone in schizophrenia in adolescents: a profile of its use.” Drugs & Therapy Perspectives, vol. 37, no. 8, 2021, pp. 347–353. https://doi.org/10.1007/s40267-021-00849-8.

Chicago

Shirley, Matt. 2021. “Lurasidone in schizophrenia in adolescents: a profile of its use.” Drugs & Therapy Perspectives 37 (8): 347–353. https://doi.org/10.1007/s40267-021-00849-8.

Harvard

Shirley, M. (2021) ‘Lurasidone in schizophrenia in adolescents: a profile of its use’, Drugs & Therapy Perspectives, 37(8), pp. 347–353. doi:10.1007/s40267-021-00849-8.

IEEE

M. Shirley, “Lurasidone in schizophrenia in adolescents: a profile of its use,” Drugs & Therapy Perspectives, vol. 37, no. 8, pp. 347–353, 2021, doi: 10.1007/s40267-021-00849-8.

BibTeX

@article{shirley2021lurasidone,
  title     = {{Lurasidone in schizophrenia in adolescents: a profile of its use}},
  author    = {Shirley, Matt},
  journal   = {Drugs \& Therapy Perspectives},
  year      = {2021},
  volume    = {37},
  number    = {8},
  pages     = {347--353},
  doi       = {10.1007/s40267-021-00849-8},
  url       = {https://doi.org/10.1007/s40267-021-00849-8}
}

Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)

Citations by year

YearCitationsShare of the best year
202211
202311
202511

Its field-weighted citation impact is 0.28: it has been cited 0.28 times as often as the average work of the same field, type and year (1.00 is the world average).

Topic and keywords

Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment

  • lurasidone
  • schizophrenia
  • adolescents
  • atypical antipsychotics
  • weight gain
  • metabolic side effects
  • drug tolerability
  • symptom improvement

Work with this paper

Most-cited papers in Medicine

All highly cited Medicine papers

Questions about this paper

How do I cite this paper in APA style?

Shirley, M. (2021). Lurasidone in schizophrenia in adolescents: a profile of its use. Drugs & Therapy Perspectives, 37(8), 347–353. https://doi.org/10.1007/s40267-021-00849-8

How many times has this paper been cited?

3 times, according to OpenAlex on 20 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.

Is this paper free to read?

OpenAlex records no free legal copy. Check your library's access, the authors' pages or a repository, or ask the corresponding author for a copy.

Who wrote this paper?

Matt Shirley.

What is the DOI of this paper?

10.1007/s40267-021-00849-8, permanently at https://doi.org/10.1007/s40267-021-00849-8. Sign in and open it from this page.

Bibliographic data from OpenAlex (CC0), last checked 20 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.